Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-11-14

Clinical Trial Update: Canadian Continuation of Roll-over Study in Patients With Endogenous Cushing's Syndrome [Phase 4]

View source ↗

Summary

Clinical trial update indicating continuation of a rollover study for Endogenous Cushing Syndrome in a Phase 4 investigation; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Centre hospitalier de l'Université de Montréal (CHUM) | Conditions: Endogenous Cushing Syndrome | Phase 4 | Status: UNKNOWN